298 related articles for article (PubMed ID: 18996572)
1. Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation.
Uemura T; Kaikita K; Yamabe H; Soejima K; Matsukawa M; Fuchigami S; Tanaka Y; Morihisa K; Enomoto K; Sumida H; Sugiyama S; Ogawa H
Thromb Res; 2009 May; 124(1):28-32. PubMed ID: 18996572
[TBL] [Abstract][Full Text] [Related]
2. Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation.
Ammash N; Konik EA; McBane RD; Chen D; Tange JI; Grill DE; Herges RM; McLeod TG; Friedman PA; Wysokinski WE
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2760-6. PubMed ID: 21852562
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
[TBL] [Abstract][Full Text] [Related]
4. Levels of von Willebrand factor and ADAMTS13 determine clinical outcome after cardioversion for atrial fibrillation.
Freynhofer MK; Bruno V; Jarai R; Gruber S; Höchtl T; Brozovic I; Farhan S; Wojta J; Huber K
Thromb Haemost; 2011 Mar; 105(3):435-43. PubMed ID: 21136020
[TBL] [Abstract][Full Text] [Related]
5. Changes in plasma von Willebrand factor-cleaving protease (ADAMTS13) levels in patients with unstable angina.
Fuchigami S; Kaikita K; Soejima K; Matsukawa M; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Nakagaki T; Sugiyama S; Ogawa H
Thromb Res; 2008; 122(5):618-23. PubMed ID: 18295305
[TBL] [Abstract][Full Text] [Related]
6. Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients.
Scridon A; Girerd N; Rugeri L; Nonin-Babary E; Chevalier P
Europace; 2013 Nov; 15(11):1562-6. PubMed ID: 23689486
[TBL] [Abstract][Full Text] [Related]
7. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery.
Hernández-Romero D; Lahoz Á; Roldan V; Jover E; Romero-Aniorte AI; Martinez CM; Jara-Rubio R; Arribas JM; Garcia-Alberola A; Cánovas S; Valdés M; Marín F
Europace; 2016 Sep; 18(9):1328-34. PubMed ID: 26566941
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.
Zhang F; Yang XC; Jia XW; Tang XH; Wang Z; Wang ZQ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4907-4912. PubMed ID: 29164570
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease.
Miura M; Kaikita K; Matsukawa M; Soejima K; Fuchigami S; Miyazaki Y; Ono T; Uemura T; Tsujita K; Hokimoto S; Sumida H; Sugiyama S; Matsui K; Yamabe H; Ogawa H
Thromb Haemost; 2010 Mar; 103(3):623-9. PubMed ID: 20135067
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
13. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
[TBL] [Abstract][Full Text] [Related]
14. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
[TBL] [Abstract][Full Text] [Related]
15. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.
Fukushima H; Nishio K; Asai H; Watanabe T; Seki T; Matsui H; Sugimoto M; Matsumoto M; Fujimura Y; Okuchi K
Shock; 2013 May; 39(5):409-14. PubMed ID: 23481506
[TBL] [Abstract][Full Text] [Related]
16. Anatomical remodeling of left atria in subjects with chronic and paroxysmal atrial fibrillation evaluated by multislice computed tomography.
Imada M; Funabashi N; Asano M; Uehara M; Ueda M; Komuro I
Int J Cardiol; 2007 Jul; 119(3):384-8. PubMed ID: 17064785
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.
Rutten B; Maseri A; Cianflone D; Laricchia A; Cristell NA; Durante A; Spartera M; Ancona F; Limite L; Hu D; Li H; Uren NG; de Groot PG; Mannucci PM; Roest M
Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):64-74. PubMed ID: 24833640
[TBL] [Abstract][Full Text] [Related]
18. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
19. Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.
Bongers TN; de Bruijne EL; Dippel DW; de Jong AJ; Deckers JW; Poldermans D; de Maat MP; Leebeek FW
Atherosclerosis; 2009 Nov; 207(1):250-4. PubMed ID: 19439298
[TBL] [Abstract][Full Text] [Related]
20. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
